Tong Shen

Tong Shen

Regeneron Pharmaceuticals Inc - Warsaw / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4417824
-
person_outline Tong Shen's MOST POPULAR ARTICLES
1-) Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2–mediated drug resistanceZ Shi, XX Peng, IW Kim, S Shukla, QS Si, RW Robey, SE Bates, T Shen, ...Cancer research 67 (22), 11012-11020, 20073222007
2-) Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone BE Hopper-Borge, X Xu, T Shen, Z Shi, ZS Chen, GD KruhCancer research 69 (1), 178-184, 20091372009
3-) Structure-guided design of potent diazobenzene inhibitors for the BET bromodomainsG Zhang, AN Plotnikov, E Rusinova, T Shen, K Morohashi, J Joshua, ...Journal of medicinal chemistry 56 (22), 9251-9264, 20131192013
4-) Distinct roles of Brd2 and Brd4 in potentiating the transcriptional program for Th17 cell differentiationKL Cheung, F Zhang, A Jaganathan, R Sharma, Q Zhang, T Konuma, ...Molecular cell 65 (6), 1068-1080. e5, 20171392017
5-) Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistanceYH Kuang, T Shen, X Chen, K Sodani, E Hopper-Borge, AK Tiwari, ...Biochemical pharmacology 79 (2), 154-161, 20101242010